(Press-News.org) In this week's PLoS Medicine, the Editors argue that drug companies should be held much more accountable for their human rights responsibilities to make medicines available and accessible to those in need. Despite decades of advocacy on the part of the access to medicines movement, and human rights guidelines developed in 2008 for pharmaceutical companies that make clear that their responsibilities go beyond stakeholder value to encompass human rights, there is inadequate accountability, say the Editors. "At the same time that the 825 billion dollar global pharmaceutical industry operates as society's chief developer and purveyor of life-saving medicine, two billion people around the world lack access to essential medicines. Such a persistent perversity demands more outrage," argue the Editors.
The editorial accompanies a series of viewpoints in a commissioned PLoS Medicine Debate on the topic of whether drug companies are living up to their human rights responsibilities. In the Debate, three unique perspectives are offered: Sofia Gruskin and Zyde Raad from the Harvard School of Public Health say more assessment is needed of human rights responsibilities; Geralyn Ritter, Vice President of Global Public Policy and Corporate Responsibility at Merck & Co. argues that multiple stakeholders could do more to help States deliver the right to health; and Paul Hunt and Rajat Khosla introduce Mr. Hunt's work as the UN Special Rapporteur on the right to the highest attainable standard of health (2002-2008), regarding the human rights responsibilities of pharmaceutical companies and access to medicines.
"The importance and significance of accountability in this area cannot be overstated," say the Editors. "Beyond an add-on or peripheral activity, the acknowledgement and promotion of human rights must become a regular, integrated aspect of the work of pharmaceutical companies. Better yet would also be an external, international body charged explicitly with monitoring the policies and practices of pharmaceutical companies and reporting publicly on the discharge of their right-to-health responsibilities."
INFORMATION:
The PLoS Medicine Editorial- Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities
Funding: The authors are each paid a salary by the Public Library of Science, and they wrote this editorial during their salaried time.
Competing Interests: The authors' individual competing interests are at http://www.plosmedicine.org/static/editorsInterests.action. PLoS is funded partly through manuscript publication charges, but the PLoS Medicine Editors are paid a fixed salary (their salary is not linked to the number of papers published in the journal).
Citation: The PLoS Medicine Editors (2010) Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities. PLoS Med 7(9): e1000344. doi:10.1371/journal.pmed.1000344
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000344
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-09-editorial.pdf
CONTACT:
Medicine_editors@plos.org
press@plos.org
The PLoS Medicine Debate: Moving Toward Assessment by Sofia Gruskin, Zyde Raad
Funding: No specific funding was received for this piece.
Competing Interests: SG is director of and ZR is program manager at the Program on International Health and Human Rights (PIHHR) at Harvard School of Public Health. PIHHR has received funding from the Merck Company Foundation for a several-year project exploring the roles and responsibilities of the pharmaceutical industry as well as other state and non-state actors with regard to alleviating disease burdens worldwide.
Citation: Gruskin S, Raad Z (2010) Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment. PLoS Med 7(9):e1000310. doi:10.1371/journal.pmed.1000310
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000310
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-09-gruskin.pdf
CONTACT:
Sofia Gruskin
sgruskin@hsph.harvard.edu
press@plos.org
The PLoS Medicine Debate: The Perspective of the Former United Nations Special Rapporteur (2002-2008) by Paul Hunt and Rajat Khosla
Funding: No specific funding was received for this article.
Competing Interests: The views expressed in this article are those of the authors and cannot be attributed to any organization.
Citation: Hunt P, Khosla R (2010) Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002-2008). PLoS Med 7(9): e1000330. doi:10.1371/journal.pmed.1000330
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000330
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-09-hunt.pdf
CONTACT:
paulhunt28@yahoo.co.uk
press@plos.org
The PLoS Medicine Debate: The Merck Perspective by Geralyn Ritter
Funding: No specific funding was received for this piece.
Competing Interests: Geralyn Ritter is Vice President, Global Public Policy and Corporate Responsibility at Merck & Co. and holds equity in Merck.
Citation: Ritter GS (2010) Are Drug Companies Living Up to Their Human Rights
Responsibilities? The Merck Perspective. PLoS Med 7(9): e1000343. doi:10.1371/journal.pmed.1000343
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000343
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-09-ritter.pdf
CONTACT:
Geralyn Ritter
geralyn.ritter@merck.com
press@plos.org
END
Whither pandemic H1N1 virus? In a new commentary, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, review the fates of previous pandemic influenza viruses in the years following a pandemic and speculate on possible future courses for the 2009 pandemic H1N1 (pH1N1) virus during the upcoming flu season and beyond.
The authors estimate that at least 183 million Americans (about 59 percent of the total U.S. population) have some immunity to pH1N1 because they were exposed to related viruses or vaccines ...
Average C-reactive protein (CRP) values vary in diverse populations — possibly impacting how doctors estimate cardiovascular risk and determine statin treatment, according to a new study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association.
CRP is a marker of inflammation, and high levels of it in the blood have been associated with a higher risk for heart disease. But it's uncertain if the association is causal. Statins are a class of cholesterol-lowering drugs that reduce heart risk and CRP. Researchers aren't certain if CRP-lowering contributes ...
DURHAM, N.C. – The yellow monkeyflower, an unassuming little plant that lives as both a perennial on the foggy coasts of the Pacific Northwest and a dry-land annual hundreds of miles inland, harbors a significant clue about evolution.
Duke graduate student and native northern Californian David Lowry had become interested in how a single species could live such different lifestyles. He set out to find a gene or genes that would account for the monkeyflower (Mimulus guttatus) being a lush, moisture-loving, salt-tolerant perennial on the coast, but a shorter, faster-flowering, ...
Healthy people who caught swine flu during the 2009 pandemic may have been protected against developing radiographically (x-ray) confirmed pneumonia by taking the antiviral drug oseltamivir (Tamiflu), concludes a study of cases in China published on bmj.com today.
The researchers also show that oseltamivir treatment was associated with shorter duration of fever and viral RNA shedding (the period when a virus is contagious), although they stress that their findings should be interpreted with caution.
In 2009, pandemic influenza A (H1N1) virus spread rapidly, resulting ...
DETROIT – The old saying, "never put anything smaller than your elbow in your ear," couldn't be truer for a patient who experienced vertigo and severe hearing loss after a cotton swab perforated her eardrum and damaged her inner ear.
But what makes this patient's case unique is that otolaryngologists at Henry Ford Hospital in Detroit were not only able to alleviate her vertigo with surgery, but restore her hearing – an extremely rare occurrence.
"This case is rare because the goal of surgery is not to recover hearing, but to improve vertigo," says case report lead ...
Playing white noise in class can help inattentive children learn. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions tested the effect of the meaningless random noise on a group of 51 schoolchildren, finding that although it hindered the ability of those who normally pay attention, it improved the memory of those that had difficulties in paying attention.
Göran Söderlund from Stockholm University, Sweden, worked with a team of researchers to carry out the experiments at a secondary school in Norway. He said, "There was significant ...
Intrauterine devices, originally developed as contraceptives, can also be used to treat and cure cancer of the endometrium according to new research published online in the cancer journal, Annals of Oncology [1] today (Wednesday 29 September). The finding opens the way for young women with the disease, which affects the lining of the womb, to be treated without the need for a hysterectomy, thus preserving their fertility until they have had all the children they want.
Endometrial cancer is the sixth most common cancer in women worldwide. In 2008 there were an estimated ...
In mice, early weaning and separation from their mothers promotes long-lasting hyperactivity and anxiety . Researchers writing in the open access journal BMC Neuroscience describe the development of this new behavioral model, which they hope to use to investigate the long-term effects of early childhood neglect in people.
Arthur Simen and a team of researchers from Yale University School of Medicine, USA, tested their 'Maternal separation with early weaning' (MSEW) model in a group of 80 male mice. He said, "Childhood adversity, in the form of abuse and neglect, is prevalent ...
The protein could provide a target to develop new treatments for the disease or enable earlier diagnosis, say the researchers from Barts and The London School of Medicine and Dentistry. Pancreatic cancer has the lowest survival rate of all cancers due to its lack of symptoms in the early stages, late diagnosis and its resistance to chemotherapy and radiation therapy.
The research – funded by the Pancreatic Cancer Research Fund – found that nearly three quarters of pancreatic cancer tumours had high levels of a protein known as P110γ. In laboratory experiments, when ...
BOSTON, Mass. (September 29, 2010) — Crowdsourcing, the act of contracting out problems to large groups rather than tapping individual experts, has solved puzzles in fields such as marketing, engineering and computer software. But can the wisdom of crowds help cure disease?
A large, multidisciplinary panel has recently selected 12 pioneering ideas for attacking Type 1 Diabetes, ideas selected through a crowdsourcing experiment called the Challenge in which all members of the Harvard community, as well as members of the general public, were invited to answer the question: ...
